Association Between Urinary Bisphenols and Body Composition Among American Adults: Cross-Sectional National Health and Nutrition Examination Survey Study (Preprint)
Preprint
- 4 June 2023
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Bisphenol A (BPA), bisphenol S (BPS), and bisphenol F (BPF) are widely used in various consumer products. They are environmental contaminants with estrogenic properties that have been linked to various health outcomes. Understanding their impact on body composition is crucial for identifying potential health risks and developing preventive strategies. However, most current studies have only focused on their relationship with BMI. OBJECTIVE This study aimed to investigate the association between urinary levels of BPA, BPS, and BPF and body composition, including BMI, lean mass, and fat mass, in a large population-based sample. METHODS We conducted a cross-sectional analysis using data from the National Health and Nutrition Examination Survey 2003-2016. Body composition data were assessed using dual-energy X-ray absorptiometry, which provided precise measurements of lean mass, fat mass, and other indicators. We used multivariate linear regression models to estimate the associations, adjusting for potential confounders such as age, gender, race, socioeconomic factors, and lifestyle variables. RESULTS The results revealed significant associations between bisphenol exposure and body composition. After adjusting for covariates, BPS showed a positive association with BMI, with quartiles 3 and 4 having 0.91 (95% CI 0.34-1.48) and 1.15 (95% CI 0.55-1.74) higher BMI, respectively, compared with quartile 1 (P<.001). BPA was negatively associated with total lean mass (TLM) and appendicular lean mass, with quartiles 2, 3, and 4 having –7.85 (95% CI –11.44 to –4.25), –12.33 (95% CI –16.12 to –8.54), and –11.08 (95% CI –15.16 to –7.01) lower TLM, respectively, compared with quartile 1 (P<.001). BPS was negatively associated with TLM, with quartiles 3 (β=–10.53, 95% CI –16.98 to –4.08) and 4 (β=–11.14, 95% CI –17.83 to –4.45) having significantly lower TLM (P=.005). Both BPA and BPS showed a positive dose-response relationship with trunk fat (BPA: P=.002; BPS: P<.001) and total fat (BPA: P<.001; BPS: P=.01). No significant association was found between BPF and any body composition parameter. CONCLUSIONS This large-sample study highlights the associations between urinary levels of BPA and BPS and alterations in body composition, including changes in lean mass, fat mass, and regional fat distribution. These findings underscore the importance of understanding the potential health risks associated with bisphenol exposure and emphasize the need for targeted interventions to mitigate adverse effects on body composition. CLINICALTRIALKeywords
All Related Versions
- Published version: JMIR Public Health and Surveillance, 9, e49652.
This publication has 45 references indexed in Scilit:
- Body Fat and Breast Cancer Risk in Postmenopausal Women: A Longitudinal StudyJournal of Cancer Epidemiology, 2013
- Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case–control study within the B∼FIT cohortEndocrine-Related Cancer, 2012
- Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional studyEnvironmental Health, 2012
- The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesityMolecular and Cellular Endocrinology, 2012
- Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly womenEnvironmental Health, 2012
- Automated on-line column-switching HPLC–MS/MS method for the quantification of triclocarban and its oxidative metabolites in human urine and serumJournal of Chromatography B, 2012
- Urinary bisphenol A and obesity: NHANES 2003–2006Environmental Research, 2011
- Skeletal muscle loss: cachexia, sarcopenia, and inactivityThe American Journal of Clinical Nutrition, 2010
- Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 DiabetesDiabetes Care, 2009
- Retracted: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer CellsEnvironmental Health Perspectives, 2008